Indeed, we see MHC-I (HLA-A/B/C and B2M) elevated in T1D α cells and correlating with worsening α scores while those expressing higher levels of immune signaling inhibitors (PIAS1, TOLLIP, and NFKBIA) associate with improved α scores. This evidence concerns the gene PIAS1 and type 1 diabetes mellitus.